Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v11-FR
Language French French
Date Updated 2018-10-17 2018-09-26
Drug Identification Number 02381559 02381559
Brand name ARZERRA ARZERRA
Common or Proper name ARZERRA 100MG VIALS ARZERRA 100MG VIALS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients Ofatumumab Ofatumumab
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML X 3 5ML X 3
ATC code L01XC L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-08-01 2017-08-01
Actual start date 2017-09-21 2017-09-21
Estimated end date
Actual end date 2018-09-26 2018-09-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Being assessed for discontinuation - communication to follow Product will be discontinued - Communication letter to follow
Health Canada comments